What made Moderna stock pop 10% on Tuesday?

Moderna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its experimental vaccine for head and neck cancer.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.MRNA-4157 has potential beyond melanoma Copy link to section The biotech giant reported positive early-stage results for its MRNA-4157 in combination with Keytruda (Merck) as a treatment of head and neck cancer this week. Analysts at J ...